ABSTRACT Splenic lymphocytes of BALB/c mice immunized with membrane-enriched fractions of human benign prostatic hyperplasia tissues were fused with the NS-1 light chain-secreting murine myeloma cell line. This generated hybridoma cultures that secreted immunoglobulins reactive in solid-phase radioimmunoassays with membrane preparations of prostatic tissues by using acetone/dry ice, and stored at -70°C. When needed, extracts ready were prepared by a modification of the method of Mehdi (10) in the presence of the protease inhibitors phenylmethylsulfonyl fluoride, pepstatin A, and aprotinin. The final membrane preparation, at 6-18 mg of protein per ml (Lowry assay) was stored at -70°C.
placed into at least three major groups-epithelium-specific, polyepithelial, and stroma-specific-on the basis of differential binding to the surfaces of various component cells in the prostate and other epithelia. Two antibodies defined unique protein antigens specific for prostate epithelia that were not crossreactive with prostatic acid phosphatase or the recently described "prostatic antigen." These antibodies also detected antigens on malignant prostate tissues as well as other malignant tissues. Four antibodies defined three unique polyepithelial protein antigens (two of the antibodies were different isotypes defining the same protein). Each of the polyepithelial antigens was expressed on a different spectrum of normal epithelial tissues. Two displayed brain tissue crossreactivity, one was present on pancreas, and one was present on platelets. The two antibodies that detected prostatic stromal protein antigens showed different spectra of reactivities. One antibody reacted with apparently all prostatic stromal cells as well as endothelial cells in the prostate and other organs. The other antibody apparently reacted with all prostatic stromal cells as well as myoepithelial and muscle cells in other organs.
The prostate gland consists of a fibromuscular stroma enclosing tubuloalveolar glands which empty their secretions into the posterior urethra. The prostrate contributes components to the semen. Its secretions include citrate, zinc, and acid phosphatase. The cell surface antigens of the prostate epithelium have received little attention.
Recently, with the use of monoclonal antibody technology, cell surface antigens specific for T lymphocytes, B lymphocytes, some colonic carcinomas, renal cell carcinomas, breast carcinomas, and malignant melanomas have been described (1) (2) (3) (4) (5) (6) (10) in the presence of the protease inhibitors phenylmethylsulfonyl fluoride, pepstatin A, and aprotinin. The final membrane preparation, at 6-18 mg of protein per ml (Lowry assay) was stored at -70°C.
For immunizations, a volume of the membrane-enriched fraction of BPH containing 100 ,ug of protein was inoculated intraperitoneally into 4-week-old BALB/c mice. At 1 month the mice were given another dose of 100 ug of membrane extract, and 3 days later the spleens were removed for cell fusion.
Hybridoma Methods. Somatic cell hybrids were prepared by using the method of Herzenberg et al. (11) . All hybridoma cell lines were cloned, and three ofthe hybridomas were cloned twice. All hybridoma supernatant fluids were assayed for antibody in a solid phase RIA with 0.2 mg of membrane preparation per ml as described (10) . Isotyping of the antibodies was performed as described (11) . Chain structure determination with [3S]methionine-labeled supernatants was performed as described with two-dimensional gels (11) . Competitive blocking with 125I-labeled (IODO-GEN) antibodies purified from ascites was by the technique of Oi (12) .
Tissue Section Immunoperoxidase Staining. Portions ofvarious normal and neoplastic human and rat tissues were obtained, frozen, cut, and stained as described (11) . Undiluted hybridoma culture supernatants were used for staining.
Abbreviations: BPH, benign prostatic hyperplasia; RIA, radioimmunoassay; FACS, fluorescence-activated cell sorter.
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Enzymatic Treatments. For studies of enzyme sensitivity of the antigenic determinants recognized by the monoclonal antibodies, membrane extracts containing 0.6 mg ofprotein were incubated in phosphate-buffered saline at 37C in the presence ofvarious enzymes as indicated in Results; then the membranes were washed by Airfuge (Beckman) centrifugation and processed for solid-phase RIA as described (10) . Enzymes tested were Pronase, neuraminidase, a-chymotrypsin, trypsinj and mixed glycosidases (Miles).
Immunoprecipitations. A membrane preparation (1800 ,ug) from BPH was divided into three equal portions, pelleted in an Airfuge, redissolved in phosphate-buffered saline, and labeled separately with "2I by using IODO-GEN, lactoperoxidase, and chloramine-T in standard methods (13) (14) (15) . After labeling, the membrane preparations were treated with 0.5% Nonidet P-40 and chromatographed on Sephadex G-25 columns. The proteinbound "I was isolated from each column and cleared with 0.25 vol of 10% staphylococcal protein A (Pansorbin, Calbiochem). The materials were then divided into 14 equal portions for each type of labeled membrane and treated with hybridoma supernatants followed by rabbit anti-mouse Ig bound to protein A as described (12 monoclonal immunoglobulins from these 13 hybridoma cell lines were studied further. The isotypes of the 13 antibodies were: IgG2a, 5; IgM, 5; and IgGI, 3 ( Table 1 ). The chain structures of the hybridoma antibodies were determined by metabolic [3S]methionine labeling of hybridoma cultures. The supernatant was precleared with protein A, immunoprecipitated with rabbit anti-mouse Ig bound to protein A, and subjected to two-dimensional gel electrophoresis. All the antibodies showed only one heavy chain and two light chains, one representing the NS-1 light chain (Fig. 1) .
Competitive blocking experiments required purification of monoclonal antibodies from malignant ascites of BALB/c mice by using either protein A-Sepharose (Pharmacia) for IgGa and IgGI or by dialysis at 4°C against distilled water for IgM. The purified antibodies were labeled with "2I and incubated with BPH membranes in the solid-phase RIA after preincubation with each of the hybridoma supernatants. Blocking produced a reduction in binding of >90% ( Antigen Characterization. Enzymatic pretreatment of the BPH membrane preparations followed by the solid-phase RIA revealed sensitivity of all the antigens to Pronase, trypsin, and chymotrypsin. Only antigen 24 was sensitive to neuraminidase as well. None was sensitive to mixed glycosidases.
Immunoprecipitation was carried out on the membrane preparations labeled with "2I by the chloramine-T, IODO-GEN, and lactoperoxidase methods. By all three methods the 25,000-dalton protein containing antigen 44 and the 90,000-and 150,000-dalton proteins containing antigen 38 were labeled (Fig. 3) .
Preliminary studies using a two-step immunofluorescence technique identical to that required for FACS analysis but performed on glass slides revealed binding of antibodies 35 Lung   35  13  8  16  2  2  2  2  2  4  2  3  2  3  20  2  3  24  13  8  4  2  3  2  2  4  2  2  2  2  3  3  2  3  67  15  10  7  6  5  4  2  2  5  7  13  7  8  10  3  4  44  24  30  9  6  8  9  12  3  13  7  2  9  14  16  11  8  45  12  7  2  1  2  4  12  2  2  2  2  2  3  10  2  2  38  13  20  2  5  5  4  2  2  5  4  14  6  12  13  14  12  48  8  15  2  1  4  4  2  2  2  2  2  12  10  3  8  2  ab2  10  10  7  8  19  20  2  2  6  3  9  10  10  16  6  10  Medium  2  2  2  2  2  3  2  2  2  2  2  2  3  2  1 30 ,ug/ml as the coating material in the solid-phase RIA, no binding of our monoclonal antibodies was seen, but xenoantisera to prostatic antigen reacted readily in the assay (unpublished data). Furthermore, the xenoantiserum to prostatic antigen failed to bind membrane extracts in the solid-phase RIA, suggesting its intracellular location. Hence, although the prostatic antigen appears to be useful diagnostically, because ofits tissue specificity, it has limited application in studying live cell function or in therapy because of its absence from surface membranes.
The other well-characterized human prostate protein is prostatic acid phosphatase (17) . Antibody to human prostatic acid phosphatase does not block binding of our antibodies in the membrane RIA (unpublished observations).
The functions of the antigens described here are unknown. We present BPH antigens that are not prostate specific but have unique distribution among human tissues. These stromal and polyepithelial antigens may be of value in studying the physiology ofvarious epithelial tissues, muscle, and endothelial cells.
We see both biological and clinical applications for these reagents. Normal prostate differentiation can be studied by immunofluorescent antibody staining of growing prostate epithelial monolayers. Ontogenic, phylogenetic, and early neoplastic events may be studied in human and other mammalian prostates. Clinically, we can investigate occult prostatic cancer and varying Gleason grades as to presence of these antigens. With F~ab)2 fragments of the prostate-specific antibodies it may be possible to localize metastases. Furthermore, the prostate-specific monoclonal antibody of IgG2a isotype, antibody 35, could be used directly to treat prostatic carcinoma patients refractory to conventional therapy, as suggested by the studies of Miller et aL (7) .
